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The alphavirus Semliki Forest virus (SFV) and its derived vectors induce apoptosis in mammalian cells.
Here, we show that apoptosis is associated with the loss of mitochondrial membrane potential followed by the
activation of caspase-3, caspase-8, and caspase-9. Cell death can be partially suppressed by treatment with the
pan-caspase inhibitor zVAD-fmk. To determine the role of SFV structural proteins in cell death, the temporal
course of cell death was compared in cells infected with SFV and cells infected with SFV virus replicon particles
(VRPs) lacking some or all of the virus structural genes. In the absence of virus structural proteins, cell death
was delayed. The endoplasmic reticulum (ER) stress response, as determined by the splicing of X-box binding
protein 1 (XBP1) transcripts and the activation of caspase-12, was activated in virus-infected cells but not in
VRP (SFV lacking structural genes)-infected cells. The C/EBP-homologous protein (CHOP) was upregulated
by both virus and VRP infections. The virus envelope proteins but not the virus capsid protein triggered ER
stress. These results demonstrate that in NIH 3T3 cells, SFV envelope glycoproteins trigger the unfolded
protein response of the ER and accelerate apoptotic cell death initiated by virus replicase activity.
Apoptosis can be triggered by many external stimuli, includ-
ing virus infections. Whereas the apoptosis of virus-infected
cells may facilitate or even be required for the release of some
viruses, this process generally is perceived as an altruistic an-
tiviral response that limits virus release and the infection of
surrounding cells (1, 58). The effectiveness of apoptosis as an
antiviral response is underlined by the existence of the many
antiapoptotic strategies employed by viruses (10, 89). Most
viral antiapoptotic responses to date have been observed in
DNA viruses. Many RNA viruses have relatively short repli-
cation times and replicate to high titers before the infected cell
undergoes cell death. These viruses may not need to suppress
apoptosis. For many RNA viruses, the mechanism, or more
likely mechanisms, by which cells detect virus infection and
initiate cell death, the temporal course of events, and whether
the virus interferes with these remain to be determined.
Alphavirus infections, including Semliki Forest virus (SFV)
and Sindbis virus (SINV), have been at the forefront of studies
of virus-induced cell death and provide important tractable
model systems to study many aspects of virus pathogenesis (2,
17, 18, 31). Alphaviruses enter cells by receptor-mediated en-
docytosis (33). Fusion occurs in endolysosomes (53). Virus
RNA replication and transcription occur in specialized invagi-
nations on smooth membrane vesicles in the cytoplasm (23,
43). The viral genome has a methylated nucleotide cap at the
5 end, is polyadenylated at the 3 end, and is translated like
cellular mRNA. The genome is split into two distinct open
reading frames (ORF) (see Fig. 4). The 5 two-thirds of the
genome encodes the nonstructural protein (nsP) ORF, which
codes for nsP-1, nsP-2, nsP-3, and nsP-4; together these form
the virus replicase that replicates and transcribes virus RNA.
The 3 one-third of the genome encodes the structural protein
ORF that codes for the capsid (C), 6K, and envelope glyco-
proteins (E1, E2, and E3) (40). The transcription of new pos-
itive-strand genomic RNA starts at the 3 end of the genome-
complementary negative strand. Late in infection, a
subgenomic mRNA is generated by the initiation of transcrip-
tion at an alternative, subgenomic promoter located 3 of the
structural genes on the negative strand. This subgenomic RNA
is translated into the virus structural proteins. The virus enve-
lope glycoproteins, as with cellular glycoproteins, are pro-
cessed through the endoplasmic reticulum (ER) and Golgi
complex (40, 41). New virions are assembled at and bud from
the plasma membrane (76, 77).
Virus replicon particles (VRPs) can be generated from many
alphaviruses, including SFV (22, 74). VRPs are structurally the
same as virus, except that the encapsidated genome lacks all or
part of the structural ORF (see Fig. 2A). Upon the infection of
a cell, VRPs replicate their genome but cannot make new virus
particles. The structural ORF can be replaced by a foreign
gene, for example, enhanced green fluorescent protein
(eGFP). Recombinant replicating alphavirus vectors and
VRPs are in development as antitumor agents and vaccines (5,
19, 81, 82).
Alphavirus infections of mammalian cells, including SFV,
SINV, Venezuelan equine encephalitis virus, and Ross River
virus, trigger apoptosis (3, 28, 35, 47, 71). Exactly how alpha-
virus apoptosis is triggered remains unclear. SINV-induced
apoptosis does not appear to require virus replication; the
entry of UV-inactivated virus into a cell can trigger ceramide
release and cell death (36, 37). In contrast, UV-inactivated
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SFV does not kill cells (86). SFV genome replication without
structural protein expression is sufficient to kill cells (29, 86). A
number of alphavirus mutants with reduced cytopathogenicity
have mutations in nsP2, and the expression of nsP2 alone is
cytotoxic (15, 20, 21, 25, 26, 30, 63, 80). The expression of the
transmembrane domains of the SINV glycoproteins also has
been shown to result in cell death (39). SINV-induced apop-
tosis is mediated by Bad, and SFV-induced apoptosis is medi-
ated by Bak (57). The apoptosis of both SINV- and SFV-
infected cells can be delayed by the overexpression of Bcl-2 or
Bcl-xl, resulting in persistently infected cultures (11, 57, 59, 71,
86). The inhibition of caspase-8 delays SINV-induced apopto-
sis, and cells deficient in caspase-9 have delayed apoptosis
following SFV infection (62, 86). Alphavirus-induced apopto-
sis has been linked to cell proliferation. The inhibition of the
cell cycle protein Ras leads to delayed cell death after SINV
infection (38). Neither p53 nor p53 upregulated modulator of
apoptosis (PUMA) is required for SFV-induced cell death
(29, 86).
The possibility that structural proteins trigger the un-
folded protein response (UPR) of the ER and that this
contributes to cell death has not been investigated for al-
phaviruses. The UPR is a cellular response to the overac-
cumulation of unfolded proteins in the lumen of the ER
(69). This response is important in the physiology of healthy
cells and functions to downregulate protein synthesis in
response to unfolded protein buildup (69). The buildup of
unfolded proteins is monitored by many ER protein chap-
erones, including immunoglobulin-binding protein (BiP).
BiP is located in the lumen of the ER and in unstressed cells
binds to the luminal domains of three ER membrane bound
proteins: eukaryotic translation initiation factor 2-alpha ki-
nase 3 (PERK), inositol-requiring protein-1 (IRE1), and
activating transcription factor-6 (ATF6). The activation of
these proteins triggers a series of events that attempt to
restore normal function by pausing translation and increas-
ing protein folding capacity. If this fails, apoptosis can be
triggered by, for example, the induction of the proapoptotic
C/EBP-homologous protein (CHOP) or by calcium-depen-
dent mitochondrial membrane permeabilization (7, 65, 72).
The aim of this study was to identify whether the SFV-
induced cell death of NIH 3T3 mouse fibroblasts involves the
extrinsic or intrinsic pathway of apoptosis, as well as to inves-
tigate whether an ER stress response is activated and whether
this contributes to cell death. We show that SFV-infected cells
have an early loss of mitochondrial membrane integrity fol-
lowed by the activation of caspase-3, caspase-8, and caspase-9,
which is indicative of the activation of the intrinsic pathway of
apoptosis. XBP-1 mRNA is spliced and caspase-12 activated
following infection with SFV but not following infection with
VRPs (lacking structural genes); CHOP, in contrast, is acti-
vated by both virus and VRP infection. By comparing the
infection of virus and VRPs lacking some or all virus structural
protein-coding sequences, we demonstrate that virus envelope
proteins, but not virus capsid protein, initiate the ER stress
response and accelerate apoptotic cell death.
MATERIALS AND METHODS
Virus and replicons. Infectious SFV4 virus was generated from the pSP6-
SFV4 plasmid by following the method of Liljestrom et al. (51). Virus was
purified through a sucrose cushion (18). EGFP-expressing VRPs were pre-
pared using pSFV1-d1eGFP (SFV replicon vector containing the nonstruc-
tural ORF and a d1eGFP gene under the control of the subgenomic pro-
moter) and SFV pHelper1 (containing the structural ORF) (18, 50). D1eGFP
is a short-half-life form of eGFP (48). A VRP, designated RC, was con-
structed to express wild-type capsid protein from the subgenomic region. A
second VRP, designated RE, was designed to express envelope glycoproteins
but no capsid protein. Both were made using the replicon plasmid pSFV1. In
RE the subgenomic promoter region is followed by 102 nucleotides (34 amino
acids [aa]) from the SFV capsid region so as to include the translation
enhancer element, followed by the foot-and-mouth disease virus autopro-
tease 2A sequence. This generates wild-type expression levels of virus enve-
lope proteins. VRPs were generated in cells cotransfected with helper RNAs
encoding the missing structural genes as described for the SFV two-helper
system (74).
Cells. NIH 3T3 cells were cultured in Dulbecco’s modified Eagle’s medium
(Gibco) with 10% newborn calf serum (Invitrogen, United Kingdom) and were
used in all experiments. Cells always were infected with SFV4 or VRPs at an
MOI of 30 (this MOI was shown by immunostaining to infect 95 to 100% of all
NIH 3T3 cells).
XBP1 analysis. At 7, 9, 11, and/or 13 h postinfection, RNA was isolated from
infected cells using a Qiagen RNeasy kit. The RNA then was reverse transcribed
and amplified by PCR with primers specific for XBP1. Primers used were the
following: forward, 5-AAACAGAGTAGCAGCGCAGACTGC-3; reverse, 5-
GGATCTCTAAAACTAGAGGCTTGGTG-3. The PCR product then was
treated with the restriction enzyme PstI (Promega) and run on an agarose gel. As
a positive control, tunicamycin was used to induce ER stress by inhibiting the
glycosylation of proteins (16, 83).
Assay of caspase activity. Cells were seeded in 96-well plates at 1  104 cells
per well, grown overnight, and infected with virus or VRPs. At various times
postinfection, cells were lysed and assayed for caspase activity. Caspase-glo-3/7,
caspase-glo-8, and caspase-glo-9 (Promega) assay kits were used according to the
manufacturer’s instructions. Assays were carried out in quadruplicate and re-
peated three times. Negative controls were mock-infected cells. Antibodies for
cleaved caspase-12, -actin (Cell Signaling) and CHOP (Santa Cruz), were used
in immunoblot analyses.
Measuring MMP. JC-1 powder (Sigma) was dissolved in dimethyl sulfoxide at
a concentration of 1 mg/ml, aliquoted, and frozen at20°C. A six-well plate, with
20- by 20-mm coverslips in all wells, was seeded with 3  105 cells per well and
incubated for 16 h at 37°C. Cells were infected or mock infected, and at various
times postinfection, medium (1 ml) containing 100 ng/ml JC-1 was added to each
well, and the plates were incubated for 1 h before visualization by fluorescence
microscopy. As a positive control (loss of mitochondrial membrane potential
[MMP]), cells were treated with 4% neutral buffered formaldehyde for 1 h.
Green (loss of MMP) and orange cells (intact MMP) were quantified by counting
cells in 15 different fields and determining the averages.
Cell viability assay. Cell viability was determined using the Wst-1 reagent
(Roche) according to the manufacturer’s instructions. Wst-1 is a tetrazolium salt
that is cleaved to a formazan dye by the active mitochondrial dehydrogenases of
live cells. Levels of dye are determined spectrophotometrically at 420 to 480 nm.
As cells lose viability, less formazan dye is made. Cells were seeded at 3 104 per
well in 96-well plates and incubated overnight. At the required time, 10 l of
Wst-1 was added to each well (containing 100 l medium). Spectrophotometric
readings were taken after 1 h using a microplate reader. Replicates of four wells
of cells were used for each time point. Experiments were repeated at least three
times.
Knockdown of caspase-12. NIH 3T3 cells were transfected with small inter-
fering RNA (siRNA) (against caspase-12 or scrambled mock) (silencer select
siRNA; Ambion) using dharmafect 1 (Thermo Scientific) and incubated for 48 h
before RNA or protein was isolated from the cells. The RNA was converted to
cDNA, and a fragment of the caspase-12 transcript was amplified. Total protein
content was probed for caspase-12 by immunoblotting using an anti-caspase-12
antibody (Cell Signaling).
Caspase inhibition. A pan-caspase inhibitor, carbobenzoxy-valyl-alanyl-aspar-
tyl-[O-methyl]-fluoromethylketone (zVAD-fmk or zVAD; Promega), was used
to inhibit caspase activity. The optimum concentration of zVAD was determined
to be 50 to 200 M. zVAD was mixed with cell culture media and added to cells
2 h before apoptotic stimulus. The apoptotic stimulus (e.g., SFV) then was
added, and the cells again were incubated with cell culture medium containing
zVAD (200 M). Cell viability was measured by Wst-1 assay.
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RESULTS
SFV4-infected cells have a loss of MMP, and SFV-induced
cell death is reduced but not completely suppressed by treat-
ment of infected cells with a pan-caspase inhibitor. The ex-
trinsic pathway of apoptosis is initiated by the ligation of cell
death receptors and includes the early activation of caspase-8.
The intrinsic pathway involves the loss of mitochondrial mem-
brane potential (MMP), the release of cytochrome c, and the
early activation of caspase-9. Both pathways activate down-
stream caspases, including caspase-3 (52). To investigate MMP
in SFV-infected cells, the cationic dye JC-1 was used (68, 75).
In mitochondria with an intact MMP, JC-1 aggregates and
fluoresces orange. The loss of MMP results in the dissociation
of these aggregates, and the JC-1 monomers fluoresce green.
Parallel cultures of NIH 3T3 cells were infected (MOI of 30)
with SFV4. This MOI resulted in the synchronous infection of
all cells in the culture (data not shown). Cells then were treated
with JC-1, and the percentage of green or orange cells was
determined at various times postinfection (Fig. 1A). Early in
infection (6 h) most cells had intact MMP (orange). MMP
disruption was apparent in 50% of cells by 8 h and in most
cells by 13 h.
We next investigated whether SFV-induced cell death in
NIH 3T3 cells could be blocked by the pan-caspase inhibitor
zVAD-fmk (zVAD). Replicate cultures were incubated with
zVAD (200 M) for 2 h and then infected with SFV4 in
medium containing the same concentration of zVAD.
Caspase-3/7 activity was assayed in zVAD-treated cultures and
was below detectable levels. The viability of the cultures was
measured at 20 and 30 h postinfection and compared to that of
uninfected or non-zVAD-treated cultures (30-h time point is
shown Fig. 1B). The zVAD-treated, SFV4-infected cultures
had a significantly higher viability than the untreated infected
cultures at both time points, indicating that zVAD had a pro-
tective effect. However, the viability of zVAD-treated cultures
infected with SFV4 was significantly lower than that of unin-
fected cultures at both 20 and 30 h postinfection. This suggests
that while caspase-dependent death is important, caspase-in-
dependent mechanisms such as the release of apoptosis-induc-
ing factor (AIF) and endonuclease G from mitochondria (12,
87) also play a role in SFV-induced apoptosis. These results
are consistent with our previous studies of the effect of zVAD
on the SFV-induced apoptosis of neuronal cells in culture (2).
SFV structural proteins contribute to virus-induced cell
death. It has been shown previously that SFV vector systems or
VRPs trigger cell death, and that the replication of the virus
replicon, the replicase gene without the structural protein
ORF, is sufficient to trigger cell death (29). How the replica-
tion of the replicon initiates apoptosis remains to be deter-
mined. It is likely that more than one aspect of virus replication
triggers cell death. Virus glycoproteins traffic through the ER
and the Golgi complex. The buildup of unfolded proteins in
the ER can lead to ER stress and, if this is not resolved,
apoptosis. ER stress has been shown to be activated and to
upregulate proapoptotic proteins in a number of virus infec-
tions (49, 55, 78). To determine whether SFV structural pro-
teins contribute to cell death, rates of cell death were com-
pared in parallel NIH 3T3 cell cultures infected with SFV4 or
VRPs at the same MOI. VRPs encapsidating an SFV genome
in which the structural ORF was replaced with d1eGFP (Fig.
2A) were used to observe the course of infection in the absence
of virus structural protein synthesis and the trafficking of virus
glycoproteins through the ER and Golgi complex; eGFP,
which does not traffic through the ER and Golgi complex, was
included as a convenient marker of infection. The viability of
FIG. 1. (A) Loss of MMP in SFV4-infected NIH 3T3 cells as visu-
alized by JC-1 staining. (a) Cells with (orange) and without (green) an
intact MMP are easily distinguished using JC-1 staining (SFV4-in-
fected NIH-3T3 cells; MOI  1.0 at 24 h). Green cells are rounded up
and condensed. The inset shows a couple of cells at higher-power
magnification (100). (b) Time course of the loss of MMP following
SFV4 infection (MOI, 30); the percentage of green cells (green line)
increased, and the percentage of orange cells (red lines) decreased.
Each point is the mean count from three replicate cultures in 15 fields
selected at random. The experiment was repeated independently twice
with similar results. (c) JC-1 staining of uninfected NIH 3T3 cells. (d)
JC-1 staining of formaldehyde-treated NIH 3T3 cells. (B) Viability
(Wst-1 assay) of NIH 3T3 cells 30 h after infection with SFV4 (MOI,
30) in the presence or absence of zVAD (200 M), a pan-caspase
inhibitor. As controls, cells were treated with staurosporine (STS; 1
M), a known inducer of apoptosis, for 30 h in the presence or absence
of zVAD or were left untreated. The bars represent the means of
quadruplicate cultures at each time point. Error bars are standard
deviations from the means. This experiment was repeated three times
with similar results.
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VRP-infected cells was significantly higher during the later
stages of infection (P  0.05, Mann-Whitney test) than that of
SFV4-infected cells (Fig. 2B), indicating that virus structural
proteins contribute to cell death.
Caspase-3/7, -8, and -9 activation is delayed in VRP infec-
tion compared to virus infection. To investigate this delay in
cell death further, a time course of the activation of caspase-
3/7, -8, and -9 in both virus- and VRP-infected NIH 3T3 cells
was determined. Replicate cultures were infected with SFV4 or
SFV VRPs, and levels of caspase-3/7, -8, and -9 were deter-
mined in quadruplicate cultures at 12, 14, 15, 16, and 18 h
postinfection (Fig. 2C). No caspase activity was observed at
12 h, but all three caspases were active by 14 to 15 h in
virus-infected cells. In VRP-infected cells, however, caspase
activation was delayed by approximately 2 h. The loss of MMP
preceded caspase activation, and the activity of all three
caspases was detected at the same time. These results indicate
that in NIH 3T3 cells the intrinsic pathway of apoptosis was
activated and are in agreement with a recent study using mouse
embryo fibroblasts in which SFV-induced apoptosis was shown
to be mediated by Bak and to proceed via the intrinsic pathway
with MMP loss, cytochrome c release, and the activation of
caspase-3, -8, and -9 (86). A delay in caspase activation in VRP
infection relative to that of virus infection suggests that the
synthesis of virus structural proteins contributes to cell death.
Levels of the ER stress-associated proteins CHOP and ac-
tivated caspase-12 in SFV- and VRP-infected cells. ER stress
can trigger apoptosis (67) and could be the additional pro-
apoptotic signal in virus-infected cells. Prolonged ER stress
leads to the activation of caspase-12, elevated levels of CHOP,
and apoptosis (54). Normally, CHOP is expressed at very low
levels and caspase-12 is present only as inactive procaspase-12.
Levels of these two proteins were determined by immunoblot
analysis of SFV4- and VRP (lacking all structural genes)-in-
fected cells at 7, 9, 11, and 13 h postinfection (Fig. 3). Unin-
fected cells and tunicamycin (5 g/ml)-treated cells were used
FIG. 2. (A) Representation of the genomes of SFV (upper) and SFV1-d1eGFP VRPs (lower). The replicase ORF comprised of nsP1 to nsP4
is present in both. In addition, the viral genome has the structural ORF comprised of the capsid (C), p62 (precursor of the E2 and E3 envelope
glycoproteins), and the E1 envelope glycoprotein. The structural ORF of the VRP genome is replaced with d1eGFP. (B) Viability (Wst-1 assay)
of uninfected NIH 3T3 cells () and NIH 3T3 cells infected (MOI, 30) with SFV4 (Œ) or VRPs (f). Each point is the mean of quadruplicate
cultures. Error bars are standard deviations from the means. The experiment was repeated three times with similar results. (C) Replicate cultures
of NIH 3T3 cells were infected (MOI, 30) with SFV4 (f) or VRPs (). Levels of activated caspase-3/7, -8, and -9 were determined at 12, 14, 15,
16, and 18 h postinfection. The bars are means from quadruplicate cultures at each time point. Error bars are standard deviations from the means.
This experiment was repeated three times with similar results.
FIG. 3. Levels of CHOP, activated caspase-12, and -actin proteins
as determined by immunoblotting in NIH 3T3 cells infected (MOI, 30)
with SFV4 or VRPs. The negative control (-ve) was mock-infected
cells. The positive control (	ve) was tunicamycin (5 g/ml)-treated
cells. This experiment was repeated three times with the same result.
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as negative and positive controls, respectively, and actin levels
were determined as a loading control. CHOP expression was
observed as early as 9 h postinfection in both SFV4- and
VRP-infected cells. CHOP is upregulated following the phos-
phorylation of eIF-2
 by the ER stress-induced kinase PERK
and other kinases, including PKR. We have previously shown
PKR to be activated in SFV-infected cells (6). In contrast,
activated caspase-12 was observed in SFV4-infected cells start-
ing at 9 h but not in VRP-infected cells, suggesting that virus
but not VRPs activate the ER stress response.
Transcripts for X-box binding protein 1 (XBP1) are spliced
in SFV- but not in VRP-infected cells. As a second marker of
the unfolded protein ER stress response, XBP1 splicing was
analyzed. The splicing of XBP1 transcripts is an early indicator
of UPR activation (8, 91). Upon the activation of the UPR,
IRE1 traffics from the ER to the cytoplasm and splices XBP1
mRNA. Splicing allows the translation of a transcription factor
that upregulates, among other genes, multiple chaperones (8,
85, 91). Replicate cultures were infected with SFV4 or VRPs
lacking all of the viral structural genes. Infection was con-
firmed by immunostaining for SFV nsP3 protein in parallel
cultures (data not shown). Total RNA was isolated at various
times postinfection and reverse transcribed into cDNA. Prim-
ers specific for XBP1 then were used to amplify the XBP1
splice variants. The splice variants, and their PCR products,
differ by only a few base pairs, which is difficult to see on an
agarose gel. The amplified DNA therefore was digested with
the restriction enzyme PstI, which cleaves a site present only in
the unspliced XBP1 mRNA (8). Spliced XBP1 RNA is not
cleaved by PstI and appears as a higher-molecular-weight
band. PstI-digested samples derived from SFV4- and VRP-
infected cells were run on a gel. PstI-treated samples derived
from uninfected cells and from tunicamycin (5 g/ml)-treated
cells served as negative and positive controls, respectively. Fol-
lowing SFV4 infection, levels of spliced XBP1 were back-
ground at 7 h but had clearly increased by 9 h (Fig. 4A). In
contrast, in VRP- and mock-infected cells, there was no splic-
ing of XBP1 even at 13 h postinfection, confirming the results
with caspase-12, that the virus replicon lacking structural genes
does not activate the UPR.
SFV envelope proteins but not the capsid protein triggers
the ER stress. To determine which of the virus structural
proteins, the capsid or envelope glycoproteins, were responsi-
ble for activating the UPR in virus-infected cells, VRPs ex-
pressing only the capsid (RC) or only the envelope glycopro-
teins (RE) were constructed (Fig. 4B). Infection with these
VRPs again was confirmed by immunostaining for nsP3 in
parallel infected cultures. RNA was isolated 13 h postinfection,
and the splicing of XBP1 transcripts was assessed (Fig. 4C).
Infection with VRPs expressing only the envelope glycopro-
teins (RE) resulted in the increased splicing of XBP1 tran-
scripts, whereas infection with VRPs expressing only the capsid
structural protein (RC) resulted in background levels of XBP1
transcript splicing. Thus, the envelope glycoproteins and not
the capsid protein triggered the ER stress response. The ex-
periment was repeated at 24 h postinfection with the same
result (data not shown).
Caspase-12 is not required for SFV4-induced mouse fibro-
blast cell death. SFV4 infection triggered the activation of
caspase-12, whereas VRP infection did not. The involvement
of caspase-12 in apoptosis remains controversial, with evidence
suggesting it plays an important role in ER stress-induced
apoptosis, while other reports suggest it is not required (61,
70). To determine whether caspase-12 activation was respon-
sible for the more rapid cell death observed in virus-infected
cells than in VRP-infected cells, rates of cell death were mea-
sured in virus-infected cells with a knockdown of caspase-12.
NIH 3T3 cells were transfected with siRNAs targeted against
caspase-12, incubated for 48 h, and then infected with SFV4
(MOI, 30). The knockdown of caspase-12 was verified both at
the transcript level by PCR and at the protein level by immu-
noblotting. Cell population viability was measured over time
using a Wst-1 assay and compared to that of infected control-
transfected cells (Fig. 5C). Following SFV infection, cells with
FIG. 4. (A) XBP1 transcript splicing in NIH 3T3 cells infected
(MOI, 30) with SFV4 or VRPs. RNA from infected cells was reverse
transcribed into cDNA, and XBP1 amplicons were generated by PCR.
These were digested with PstI, which only cleaves amplicons derived
from unspliced XBP1 transcripts. The digests were run on an agarose
gel (shown). The upper (undigested) band represents spliced transcript
and the lower (digested) band unspliced transcript. The negative (-ve)
control was RNA from mock-infected cells. The positive (	ve) control
was RNA from tunicamycin (5 g/ml)-treated cells. The ladder (L) is
a 1-kb DNA ladder (Promega) showing 250-bp (lower), 500-bp (mid-
dle), and 750-bp (upper) bands. (B) Genome structure of SFV4 (V),
VRPs expressing the nonstructural and envelope proteins only (RE),
VRPs expressing the nonstructural and the capsid protein only (RC),
or VRPs lacking all structural genes (R) used to infect (MOI, 30) NIH
3T3 cells. (C) Following infection with the virus or VRPs from panel
B, XBP1 transcript splicing was assessed (as described above) at 13 h
postinfection. The negative control (-ve) was RNA from mock-infected
cells. The positive control (	ve) was RNA from tunicamycin (5 g/
ml)-treated cells. The ladder (L) was a 100-bp DNA ladder (New
England Biolabs). The experiment was repeated three times with sim-
ilar results.
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a knockdown of caspase-12 died at the same rate as control
cells, suggesting that caspase-12 is not required for cell death
and is not responsible for the more rapid death of virus-in-
fected than VRP-infected NIH 3T3 cells.
DISCUSSION
The alphavirus infection of mammalian cells generally trig-
gers apoptosis, but the pathways involved remain to be deter-
mined. Here, we demonstrate the loss of MMP before the
coincident activation of caspase-3, -8, and -9, a course of events
indicative of the activation of the intrinsic pathway of apoptosis
and in agreement with another recent study of the SFV infec-
tion of primary mouse embryo fibroblasts (86). Importantly, in
the absence of virus envelope proteins, ER stress is not acti-
vated, caspase activation is delayed, and cell death is slowed
down (compared to whole-virus infection).
Despite the synchronous infection of virtually all cells in the
culture, JC-1 staining indicated that not all cells lost their
membrane potential synchronously. The viability of infected
cultures declined progressively from 10 to 26 h postinfection. It
is likely that cells responded at different rates to infection,
which is consistent with the suggestion that the cell cycle affects
alphavirus-induced apoptosis (38).
Mitochondrial membrane disruption very early in infection
could result from a number of factors. One possibility is that
SFV directly interacts with mitochondria as part of the virus
life cycle. Some viruses, for example, flock house virus, repli-
cate on the outer membranes of mitochondria, and rubella
virus, a close relative of the alphaviruses, associates with mi-
tochondria during replication (45, 56). However, there have
been numerous electron microscopic studies of alphavirus rep-
lication with no reports associating virus replication with mi-
tochondria (43). SFV replicates on endosome-like vacuoles
(23). It is more likely that the disruption of mitochondrial
membranes occurs as a result of the activation of proapoptotic
events. Bak is known to cause cytochrome c release from mi-
tochondria and disrupt MMP and recently has been shown to
play an important role in SFV-induced apoptosis in primary
mouse fibroblasts, and in BHK cells SINV apoptosis is induced
by the related protein Bad (57, 86). It is not clear how alpha-
viruses activate these BH3 domain Bcl2 family proapoptotic
proteins. One possibility is through the activation of p53 (90).
However, SFV is not known to perturb nuclear events likely to
activate p53, and p53 is not essential for SFV-induced cell
death (29). Other more likely possibilities include the detec-
tion of virus RNA by RIG-I-like helicases, IPS-1-induced cell
death, or the virus-induced disruption of cellular transcription
or translation (13, 25, 34, 46, 64).
Apoptosis is activated by the replication of SFV replicons
that do not contain the virus structural coding sequences, in-
dicating that the virus structural proteins are not required for
cell death (29). However, as we show here, their presence
accelerates cell death. SFV is an enveloped virus, and the viral
envelope glycoproteins are made on and traffic through the
ER. Here, we demonstrate that the UPR of the ER is activated
by infection with SFV, but not by infection with SFV VRPs
lacking the virus structural protein-coding region. A number of
other viruses also have been shown to activate the UPR, in-
cluding West Nile, Tula, and vesicular stomatitis viruses (24,
49, 55). The West Nile virus (WNV) infection of neuronal cells
results in XBP1 splicing, the phosphorylation of eIF-2
, and
the upregulation of CHOP (55). Hepatitis C virus envelope
glycoproteins expressed alone are sufficient to upregulate BIP
expression and activate the UPR (9). Mutations in the SFV E2
glycoprotein reduce cytotoxicity, while the isolated expression
of SINV glycoproteins triggers apoptosis (27, 39, 84). These
effects may be mediated by the ER UPR.
The capsid protein of WNV can suppress the expression of
OASIS, an ER stress-related protein (42, 88). This raises the
possibility that alphavirus capsid proteins also affect ER stress.
The capsid protein of new world alphaviruses such as Western
and Venezuelan equine encephalitis viruses is known to play a
significant role in the shutdown of transcription and translation
in infected cells (4, 26). Using VRPs expressing nsPs and either
capsid protein only or envelope proteins only, we specifically
show that the envelope proteins are responsible for the acti-
vation of ER stress and that the capsid protein is not involved.
CHOP was upregulated by both SFV4 and VRP infection.
CHOP has proapoptotic activity; it suppresses Bcl-2 expres-
sion, allowing proapoptotic proteins to trigger apoptosis (54).
CHOP expression began between 7 and 9 h following infection
with either SFV or VRPs. Therefore, while CHOP may con-
tribute to apoptosis, it seems unlikely to be responsible for the
FIG. 5. Rate of cell death was unaffected by a knockdown of
caspase-12. (A) NIH 3T3 cells were treated (	ve) with siRNA against
caspase-12 (C-12) or with a scrambled control siRNA (-ve). The effects
on caspase-12 and, as a control, -actin transcripts were determined by
PCR. (B) Caspase-12 and -actin protein levels after siRNA treat-
ment. (C) NIH 3T3 cells treated with siRNA against caspase-12 (f) or
control siRNA (Œ) were infected (MOI, 30) with SFV4, and cell
viability (Wst-1 assay) was measured over time. Uninfected cells ()
were included as a control. This was repeated three times with similar
results.
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different rate of apoptosis between SFV4- and VRP-infected
cells. CHOP upregulation in VRP-infected cells probably re-
sults from the activation of PKR. PKR activated by (viral)
double-stranded RNA (dsRNA) phosphorylates eIF-2
, lead-
ing to ATF4 translation and CHOP upregulation (32). PKR is
activated by SFV infection but is not required for SFV-induced
apoptosis (6); indeed, PKR delays SFV-induced apoptosis,
probably as a result of its inhibition of early events in virus
replication (6). The activation of the UPR results in the acti-
vation of PERK, which also phosphorylates eIF-2
, resulting
in the translation of ATF4 and CHOP (79). CHOP and ATF4
expression thus are a consequence of eIF-2
 phosphorylation
resulting from the activation of either PKR or PERK and
therefore are not exclusive markers of ER stress. XBP1 splic-
ing and caspase-12 activation are more specific markers of ER
stress and were observed only in SFV4-infected, not VRP-
infected, cells.
The primary route by which ER stress induces apoptosis is
likely to be the release of Ca2	 from the ER. This builds up in
the mitochondria, leading to membrane permeabilization and
apoptosis (14). The activation of caspase-12, located on the
cytoplasmic surface of the ER and activated by calpains as a
result of calcium ion release (60, 66), is an agreed marker of
this stress response, but the role of caspase-12 activation in
apoptosis is controversial. Caspase-12 activation has been sug-
gested to be essential for ER stress-induced apoptosis (61).
However, more recent studies have shown that caspase-12 is
more likely to play a role in the control of inflammation (73);
caspase-12 negatively regulates caspase-1 (70) and NOD sig-
naling (44). Using siRNA, we were unable to ablate caspase-12
expression, but a strong reduction in protein levels was at-
tained. Following SFV infection, these cells died at the same
rate as control cells, suggesting that activated caspase-12 is not
required and does not contribute to cell death in response to
ER stress initiated by SFV infection.
In summary, in NIH 3T3 cells, SFV infection triggers the
intrinsic pathway of cell death, strongly upregulates CHOP,
and activates the unfolded protein stress response of the ER.
This ER stress response is activated by the virus envelope
glycoproteins and not by virus capsid protein, and indepen-
dently of caspase-12, it accelerates apoptotic cell death trig-
gered by the replicon. Even for a relatively simple RNA virus,
it is clear that cell death is triggered by more than one aspect
of the virus-cell interaction; in the case of SFV, events inde-
pendent of and dependent on virus envelope proteins are cru-
cial.
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